Clinical Trials Logo

Clinical Trial Summary

The purpose of this proposed project is to test whether several biological factors (such as elevated brain reward region and attention region response to high-calorie foods, weaker inhibitory region response to high-calorie foods, habitual caloric deprivation, and elevated limbic region responsivity) increase the risk of problematic eating (bingeing and purging) in female adolescents.


Clinical Trial Description

Participants will be adolescent girls aged 13-16, some of whom will have parental history of eating pathology. Participants will be recruited from the general population but their age, gender, and the presence of parental lifetime eating pathology will create a high-risk sample. The goals of the proposed project are to (1) conduct a prospective high-risk study to test whether proposed biological risk factors predict the future onset of core ED symptoms (e.g., binge eating, compensatory behaviors); (2) test hypotheses regarding how these biological risk factors and established self-report ED risk factors may work together to predict ED behavior onset; (3) examine if certain biological factors account for the effects of certain established self-reported ED risk factors (e.g., elevated brain response to thin models accounts for the effect of questionnaire-measured thin-ideal internalization). The participants will complete a baseline assessment and then follow-ups assessments over a span of three years. In addition, participants will complete one fMRI scan after the first assessment. During the COVID-19 shelter-at-home order, the investigators will not measure in person only outcomes including fMRI scans, height and weight measurement for BMI calculation nor IAT computer paradigms for all participants that have assessments due during this order. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03687346
Study type Observational
Source Oregon Research Institute
Contact
Status Completed
Phase
Start date August 3, 2017
Completion date October 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT03317587 - Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE) N/A
Completed NCT03197519 - Evaluation of a Program for Eating Disorders That Combines Cognitive-behavioral Therapy With Online Psychological Treatment N/A
Withdrawn NCT02978742 - Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder N/A
Completed NCT03013244 - Reducing Eating Disorder Risk Factors Among College-Aged Males N/A
Completed NCT02419326 - Uniting Couples In the Treatment of Eating Disorders (UNITE) N/A
Completed NCT00184301 - A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder. N/A
Recruiting NCT03503981 - Examining Change Mechanisms in Psychotherapy
Completed NCT03911674 - Effects of Oral Stimulation in Preterm Infants Phase 3
Completed NCT03097874 - Adaptive Treatment for Adolescent Anorexia Nervosa N/A
Recruiting NCT03218670 - Your Health in On Click N/A
Completed NCT03292146 - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study Phase 3
Completed NCT03502564 - Integrated Treatment for Co-occurring Eating Disorders and Posttraumatic Stress Disorder N/A
Recruiting NCT02960152 - Periodontal Impact of Eating Disorders (the PERIOED Study) N/A
Completed NCT01985178 - Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders N/A
Terminated NCT01183377 - Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007 N/A
Completed NCT00000448 - Naltrexone Treatment for Alcoholic Women Phase 4
Completed NCT06230107 - The Effects of Nutritional Intervention in Participants With Eating Disorders. N/A
Completed NCT03712748 - Online Imaginal Exposure N/A
Completed NCT04091477 - Impact of Neuropsychological Alteration of Patients With Eating Disorders
Completed NCT03317379 - Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy N/A